These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5746834)

  • 1. [Use of oxybutynin hydrochloride in the treatment of primary dysmenorrhea].
    Piato S; Delascio D
    Matern Infanc (Sao Paulo); 1968; 27(2):95-101. PubMed ID: 5746834
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anticholinergic treatment in the therapy of primary enuresis. Effectiveness of oxybutynin chloride in a controlled clinical study of 58 patients].
    Marconi AM; Felici E; Roggia A; Torelli F
    Pediatr Med Chir; 1985; 7(4):573-6. PubMed ID: 3915547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hyperhidrosis with oxybutynin.
    Schollhammer M; Misery L
    Arch Dermatol; 2007 Apr; 143(4):544-5. PubMed ID: 17438194
    [No Abstract]   [Full Text] [Related]  

  • 4. Terodiline and oxybutynin in detrusor instability.
    Drug Ther Bull; 1988 May; 26(10):37-8. PubMed ID: 3383752
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of unstable bladder with oxybutynin hydrochloride. Our clinical experience in 80 cases].
    Alladio F; Arena G; Ferrando U; Pigato M; Sesia G
    Minerva Urol Nefrol; 1987; 39(4):359-62. PubMed ID: 3451374
    [No Abstract]   [Full Text] [Related]  

  • 6. Oxybutynin therapy for generalized hyperhidrosis.
    Tupker RA; Harmsze AM; Deneer VH
    Arch Dermatol; 2006 Aug; 142(8):1065-6. PubMed ID: 16924061
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome.
    Schaefer W
    Int J Urol; 2007 Jul; 14(7):670; author reply 670-1. PubMed ID: 17645621
    [No Abstract]   [Full Text] [Related]  

  • 8. [Oxybutynin chloride in pediatrics: extenuating circumstances].
    Aubert D
    Arch Fr Pediatr; 1988 May; 45(5):375-6. PubMed ID: 3415420
    [No Abstract]   [Full Text] [Related]  

  • 9. Oxybutynin for diabetic complications.
    Chideckel EW
    JAMA; 1990 Dec; 264(23):2994. PubMed ID: 2243424
    [No Abstract]   [Full Text] [Related]  

  • 10. Oxybutynin administration diminishes the high gastric muscular tone associated with bladder reconstruction.
    Sheldon CA; Reeves D; Lewis AG
    J Urol; 1995 Feb; 153(2):461-2. PubMed ID: 7815620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tethered cord syndrome in an adult. Pharmacological treatment of the urological symptomatology by oxybutynin.
    De Angelis M; Martina G; Caverni L; Coglitore A; Libanori GP; Giannotti P
    Acta Urol Belg; 1986; 54(1):99-105. PubMed ID: 3962800
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitative characterization of therapeutic index: application of mixed-effects modeling to evaluate oxybutynin dose-efficacy and dose-side effect relationships.
    Gupta SK; Sathyan G; Lindemulder EA; Ho PL; Sheiner LB; Aarons L
    Clin Pharmacol Ther; 1999 Jun; 65(6):672-84. PubMed ID: 10391673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parasympatholytic agents in duodenal ulcer. Double-blind controlled trial with oxyphencyclimine hydrochloride.
    Goyal RK; Bhardwaj OP; Chuttani HK
    J Indian Med Assoc; 1968 Apr; 50(8):365-7. PubMed ID: 4874902
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful Treatment of Neoplastic Fever with Oxybutynin.
    Yarchoan M; Tucker W; Smith TJ
    J Palliat Med; 2019 Dec; 22(12):1491. PubMed ID: 31794374
    [No Abstract]   [Full Text] [Related]  

  • 15. Can oxybutynin cause peripheral neuropathy?
    Patel HR; Albehussi S; Arya M; Miller RA
    J Urol; 2002 Aug; 168(2):646. PubMed ID: 12131334
    [No Abstract]   [Full Text] [Related]  

  • 16. Oxybutynin and incontinence during grand mal seizures.
    Harari D; Malone-Lee JG
    Br J Urol; 1991 Dec; 68(6):658. PubMed ID: 1773301
    [No Abstract]   [Full Text] [Related]  

  • 17. [Topical treatment with oxybutynin chloride in neurogenic incontinence].
    López Pereira P; Martínez MJ; Muguerza R; Jaureguizar E
    Cir Pediatr; 1993 Jan; 6(1):29-31. PubMed ID: 8499234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxybutynin: a new drug with analgesic and anticholinergic properties.
    Diokno AC; Lapides J
    J Urol; 1972 Aug; 108(2):307-9. PubMed ID: 5047425
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of functional dysmenorrhea with RO 4-6161].
    Branger F
    Praxis; 1966 Sep; 55(38):1083-7. PubMed ID: 6013411
    [No Abstract]   [Full Text] [Related]  

  • 20. An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder.
    Goldenberg MM
    Clin Ther; 1999 Apr; 21(4):634-42. PubMed ID: 10363730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.